Breaking News: Trump administration impacts continue to roil the life sciences sector Home » WLB-83038, a small-molecule candidate with new dual mode of action to treat pain ...
– Positive results from ALLEVIATE-1 Phase 3 pivotal trial for cebranopadol which demonstrates statistically significant pain reduction compared to placebo in patients after abdominoplasty will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback